The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Brain peptides in Alzheimer's disease pathophysiology and therapeutic advances Cell and Tissue Research Springer Nature Link Molecular mechanisms underlying cyclophosphamide induced cognitive impairment and strategies for neuroprotection in preclinical models Molecular and Cellular Biochemistry Springer Nature Link DIHEXA is a neurogenic peptide designed to enhance cognitive function by increasing synaptic density in the brain. Unlike stimulants that offer temporary boosts, Dihexa supports long term brain health improving communication between